Oman Gene Synthesis Research Use Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

Oman Gene Synthesis Research Use Market Overview

• The Oman Gene Synthesis Research Use Market is valued at USD 6 million, based on a five-year historical analysis and its share within the broader Middle East DNA synthesis market, which was estimated at about USD 45 million for the region. This growth is primarily driven by advancements in biotechnology, increasing investments in research and development, and a rising demand for synthetic biology applications across healthcare and industrial sectors in the Middle East. The market is further supported by the growing need for personalized medicine, genomics-driven research, and molecular diagnostics, which has led to an increase in gene synthesis and related DNA synthesis services in academic, hospital, and industrial laboratories.
• Key hubs influencing demand in this market include Muscat, Salalah, and Sohar, which benefit from their strategic locations, access to universities, hospitals, and applied research centres, and targeted government initiatives to build biotechnology and life sciences capabilities. These cities host institutions such as Sultan Qaboos University and growing healthcare and industrial clusters that foster innovation and collaboration in genomics, molecular biology, and synthetic biology, making them pivotal in the growth of demand for gene synthesis services procured from regional and global vendors.
• Biotechnology-related research and genetic technologies in Oman are supported by national science, innovation, and health frameworks such as the Vision Oman 2040 implementation plans and research funding channels overseen by the Ministry of Higher Education, Research and Innovation and the Ministry of Health, which encourage investment in genomics, molecular diagnostics, and advanced laboratory capabilities. In addition, activities involving genetic resources and biosafety are guided by instruments such as the Royal Decree No. 118/2004 ratifying Oman’s accession to the Cartagena Protocol on Biosafety under the Convention on Biological Diversity, which sets operational requirements for the safe transfer, handling, and use of living modified organisms, including risk assessment, documentation, and regulatory approvals for certain categories of genetic and biotechnological work.

Oman Gene Synthesis Research Use Market Segmentation

By Service Type:The service type segmentation includes various offerings such as Oligonucleotide Synthesis, Gene Synthesis, Gene Fragments & Libraries, and Plasmid DNA & Cloning Vectors. In the broader Middle East DNA synthesis market, the oligonucleotide synthesis segment currently accounts for the largest share of revenues, driven by its extensive use in research, diagnostics, and therapeutic development. Within research-use gene synthesis services specifically, demand for Gene Synthesis and Gene Fragments & Libraries is expanding rapidly due to their application in synthetic biology, vaccine and therapeutic target discovery, and engineered protein and pathway design, while Plasmid DNA & Cloning Vectors remain essential for routine molecular biology workflows.

By Application:The application segmentation encompasses Research and Development, Synthetic Biology & Genetic Engineering, Diagnostics Assay Development, and Vaccine & Therapeutic Development (Pre-clinical / Research Use Only). In the Middle East DNA synthesis market, the Research and Development application segment held the leading share of more than sixty percent of revenues, reflecting strong focus on basic and applied research in genomics, molecular biology, and genetic engineering across universities, research institutes, and healthcare systems. Synthetic Biology & Genetic Engineering, together with Vaccine & Therapeutic Development (pre-clinical), are among the fastest-growing research-use segments as organizations leverage gene synthesis for construct design, pathway engineering, and candidate screening, while Diagnostics Assay Development is supported by continued use of synthesized oligos and genes in PCR, sequencing, and molecular test development.

Oman Gene Synthesis Research Use Market Competitive Landscape

The Oman Gene Synthesis Research Use Market is characterized by a dynamic mix of regional and international players. Leading participants such as Thermo Fisher Scientific, Inc., Integrated DNA Technologies, Inc. (IDT), GenScript Biotech Corporation, Eurofins Genomics, Twist Bioscience Corporation, DNA Script, Bio-Synthesis Inc., Bioneer Corporation, ATUM, Inc., LGC Biosearch Technologies, Agilent Technologies, Inc., Genewiz (Azenta Life Sciences), Jena Bioscience GmbH, Macrogen Inc., Local & Regional Players (e.g., AlGenome International and GCC-focused distributors) contribute to innovation, geographic expansion, and service delivery in this space.

Oman Gene Synthesis Research Use Market Industry Analysis

Growth Drivers

• Increasing Demand for Synthetic Biology Applications:The synthetic biology market in Oman is projected to reach $1.2 billion in future, driven by the rising need for innovative solutions in healthcare and agriculture. The World Bank reports that Oman’s biotechnology sector has seen a 15% annual growth rate, reflecting a robust interest in synthetic biology applications. This demand is fueled by the need for sustainable agricultural practices and advanced medical therapies, positioning Oman as a key player in the regional biotechnology landscape.
• Advancements in Gene Editing Technologies:The introduction of CRISPR and other gene editing technologies has revolutionized research capabilities in Oman. In future, the global gene editing market is expected to exceed $10 billion, with significant contributions from Omani research institutions. The Sultanate's investment in biotechnology infrastructure, including a $50 million fund for research initiatives, supports the adoption of these technologies, enhancing the efficiency and precision of gene synthesis processes.
• Rising Investment in Biotechnology Research:Oman has increased its biotechnology research funding to $30 million in future, reflecting a commitment to advancing the sector. This investment is crucial for developing innovative gene synthesis techniques and fostering collaborations with international biotech firms. The government’s focus on diversifying the economy away from oil dependency has led to a surge in research activities, positioning Oman as a competitive player in the global biotechnology arena.

Market Challenges

• High Costs Associated with Gene Synthesis:The cost of gene synthesis in Oman can reach up to $500 per gene, which poses a significant barrier for many research institutions. This high expense limits access to advanced genetic research, particularly for smaller entities and startups. As the global average cost of gene synthesis decreases, Omani firms must find ways to reduce their operational costs to remain competitive in the market.
• Regulatory Hurdles in Biotechnology:The regulatory framework for biotechnology in Oman is still developing, leading to uncertainties for firms engaged in gene synthesis. Compliance with existing regulations can delay research projects, with approval processes taking up to six months. This regulatory environment can deter foreign investment and slow down the pace of innovation, hindering the growth of the gene synthesis market in the region.

Oman Gene Synthesis Research Use Market Future Outlook

The future of the gene synthesis market in Oman appears promising, driven by ongoing advancements in technology and increasing government support. As research institutions expand and collaborate with international partners, the market is likely to witness significant growth. Additionally, the integration of artificial intelligence in gene synthesis processes is expected to enhance efficiency and reduce costs, making gene synthesis more accessible. The focus on ethical considerations will also shape the regulatory landscape, fostering a more conducive environment for innovation.

Market Opportunities

• Expansion of Research Institutions in Oman:The establishment of new research centers, with an investment of $20 million in future, presents a significant opportunity for the gene synthesis market. These institutions will drive innovation and collaboration, enhancing the overall research ecosystem in Oman and attracting global talent and investment.
• Collaborations with International Biotech Firms:Partnerships with established biotech companies can facilitate knowledge transfer and access to advanced technologies. Such collaborations are expected to increase by 30% in future, providing Omani firms with the expertise needed to enhance their gene synthesis capabilities and expand their market reach.